Speakers

Matthew Cato

Senior Director Cell & Gene Therapy • Mission Bio

Matthew Cato is a business and market development leader who specializes in cell and gene therapies and precision medicine. With a background in immunology and biotechnology, he focuses on strategic commercial development for single-cell technology to advance cell and gene therapeutic solutions

Also Speaking

Image

Allen Feng

Co-Founder and Chief Scientific Officer • HebeCell Corp
21 December 2021
Image

Maia Hansen

Chief Operating Officer • Athersys
31 October 2022
Image

Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc
9 November 2022

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
21 March 2023
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023